Recent Finacing
Recent Raise
DiscoveryBioMed develops human-cell–based drug discovery platforms and high-throughput screening assays to identify small-molecule therapeutics targeting adiponectin upregulation and other pathways for metabolic, cystic fibrosis, hypertension, and kidney diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
